Location History:
- Hannover, DE (2011 - 2017)
- Langenhagen, DE (2021)
Company Filing History:
5 out of 23 
1 out of 1 Years Active: 2011-2021
Title: Innovations of Thomas Ebensen
Introduction
Thomas Ebensen is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic compounds. With a total of six patents to his name, his work focuses on innovative solutions for vaccination and disease treatment.
Latest Patents
Ebensen's latest patents include groundbreaking inventions such as lipopeptide- and lipoprotein-conjugates. These compounds are designed for therapeutic or prophylactic vaccination, offering new methods for mucosal and systemic administration. His inventions also encompass cyclic-dinucleotides and their conjugates, which serve as adjuvants in pharmaceutical compositions, particularly vaccines. These innovations aim to enhance the efficacy of treatments for infectious diseases, inflammatory conditions, autoimmune diseases, and even cancer.
Career Highlights
Throughout his career, Thomas Ebensen has worked with esteemed organizations, including the Helmholtz Centre for Infection Research. His research has significantly advanced the understanding of immunomodulation and vaccine development. His contributions have been pivotal in creating new adjuvants that improve vaccination strategies.
Collaborations
Ebensen has collaborated with notable colleagues such as Michael Morr and Carlos Alberto Guzman. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Thomas Ebensen's work exemplifies the spirit of innovation in biotechnology. His patents and research contributions are paving the way for new therapeutic approaches to combat various diseases. His dedication to advancing medical science continues to inspire future developments in the field.